The Department of Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation (ASPE) continued its research series on the Inflation Reduction Act this week with a look at the impact of the $2,000 Part D out-of-pocket cap on prescription drugs.
Under the Inflation Reduction Act (IRA), 11 million Medicare Part D...National Reports & Surveys
During COVID-19, rules constricting the use of telehealth were waived, opening doors for enrollees in Medicaid to receive behavioral health services through such technology. As a result, providers rapidly shifted their services to focus on telehealth availability, which may have unintended consequences for certain populations.
The...
Over 12% of Part D enrollees faced copayments over $20 for a single fill of a generic drug. Fills for more than $2 were common, and accounted for nearly half of some prescriptions. The federal government has outlined plans for the Medicare $2 Drug List (M2DL) Model, which would create a high-value generic drug list that Part D drug plan...
